Monopar Therapeutics Inc.

549300QJFAI7L6YHKG83

The entity

Status: Active
LEI status: Lapsed - not renewed
Category: Company
Legal form: Corporation (XTIQ)
Jurisdiction: US-DE

Address

Country: United States
Legal address: C/O Corporation Trust Company, Corporation Trust Center, 1209 Orange Street19801 WilmingtonUnited States (US-DE)
Head office: 5 Revere Drive, Suite 20060062 NorthbrookUnited States (US-IL)

Identifier

LEI: 549300QJFAI7L6YHKG83
Registered: May 14, 2018 at 03:33 PM UTC
Last updated: August 4, 2023 at 05:08 PM UTC
Next renewal: May 11, 2019 at 08:44 PM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: Division of Corporations, Department of State (RA000602)
Identifier: 5652577
Verified against: Division of Corporations, Department of State (RA000602)
Verified as: 5652577
Corroboration: Confirmed against a public register
GLEIF conformity: Does not meet the standard

Corporate structure

Why no parent is reported

No direct parent reportedNo ultimate parent reported: The accounts are not published

Machine access

REST: https://lei.online/v1/entities/549300QJFAI7L6YHKG83This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search